Advances in Parkinson’s Disease Cell Therapy: XellSmart Launches a Multicenter Phase II Clinical Trial Following Encouraging Phase I Results

B SUZHOU, China, April 14, 2026 /PRNewswire/ — In April 2026, XellSmart officially launches its multicenter Phase II registrational clinical trial of the “Clinical-Grade, Allogeneic, Off-the-Shelf, iPSC-Derived,…
posteditor
posteditor
Articles: 16137

Other News